Salt Lake-based Myriad Genetics and North Carolina-based Laboratory Corp. of America Holdings have formed a partnership to make Myriad's predictive medicine products broadly available to primary care physicians throughout the United States.

Through the agreement, LabCorp becomes Myriad's exclusive sales and distribution partner, marketing the products through its 600-person U.S. sales force. Myriad will continue to market its products to oncologists through its own 85-person oncology sales force.

The agreement includes all of Myriad's predictive medicine products, including the company's three cancer predictive products and its hypertension predictive products.

Those products are to be marketed nationally to LabCorp's more than 200,000 physician customers. Myriad will perform the comprehensive DNA sequence-based tests at its molecular diagnostics facility in Salt Lake.

LabCorp, a national laboratory, had annual revenues of $1.9 billion in 2000. It has more than 18,000 employees and offers more than 4,000 clinical tests.